Sirolimus as Therapeutic Approach to Uveitis

NCT00908466 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Uveitis
Intermediate Uveitis
Posterior Uveitis
Panuveitis

Interventions

DRUG: Sirolimus (rapamycin)
DRUG: Sirolimus (rapamycin)

Sponsor

Johns Hopkins University

Collaborators

[object Object]